Summit Therapeutics SMMT
NASDAQ SMMT
$17.08 -0.75 (-4.21%)
As of: Nov 11, 2026 · 11:41 AM EST

Summit Therapeutics (SMMT) Total Non-Current Liabilities (2014 - 2026)

Updated

Summit Therapeutics (SMMT) posted Total Non-Current Liabilities of $126.36 million for Q3 2026, up 86.8% from $67.64 million a year earlier and up 4.9% from the prior quarter.

Analysis

Summit Therapeutics (SMMT) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, Summit Therapeutics' Total Non-Current Liabilities came in at $90.49 million, up 100.3% from FY2024.

  • Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of 34.5% (FY2020 to FY2025).
  • In prior years, Summit Therapeutics' Total Non-Current Liabilities was $45.18 million in FY2024 (-63.5%), $123.7 million in FY2023 (-76.9%), $536.09 million in FY2022 and $27.31 million in FY2021 (+33.0%).
  • The Q3 2026 figure stands as the highest quarterly Total Non-Current Liabilities since Q2 2024.
  • On a year-over-year basis, Total Non-Current Liabilities has increased in each of the last five quarters, with growth averaging 32.5% over the last eight quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q3 2023, with growth of 498.4%; the weakest was Q4 2023, with a decline of 76.9%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $120.4 million (Q2 2026), $100.13 million (Q1 2026) and $90.49 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 102.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 117.60 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -36.84 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.05 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 96.04 Bn
10 Summit Therapeutics 14.26 Bn 11.63 Bn - 126.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 126.36 Mn
Jun 30, 2026 120.40 Mn
Mar 31, 2026 100.13 Mn
Dec 31, 2025 90.49 Mn
Sep 30, 2025 67.64 Mn
Jun 30, 2025 62.76 Mn
Mar 31, 2025 37.78 Mn
Dec 31, 2024 45.18 Mn
Sep 30, 2024 63.22 Mn
Jun 30, 2024 145.19 Mn
Mar 31, 2024 129.26 Mn
Dec 31, 2023 123.70 Mn
Sep 30, 2023 117.62 Mn
Jun 30, 2023 116.26 Mn
Mar 31, 2023 119.93 Mn
Dec 31, 2022 536.09 Mn
Sep 30, 2022 19.66 Mn
Jun 30, 2022 41.81 Mn
Mar 31, 2022 49.31 Mn
Dec 31, 2021 27.31 Mn
API Access

Summit Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SMMT&period=max&api_key=YOUR_API_KEY